Five-Year Validity and Renewal of Medical Device Registrations in Myanmar

1. Key takeaways

The validity period of a Myanmar medical device registration certificate is 5 years. A renewal application should be submitted at least 6 months in advance to avoid interruption of imports. Renewal typically requires submission of updated product information, evidence of the continued conformity of the quality system, and an updated report on safety and effectiveness. Companies that plan around these three elements early in the certificate’s life find the renewal far easier to complete than those who treat it as a last-minute filing.

GRZAN insight: the 6-month lead time is a practical estimate (drawn from multiple recorded sources), not an explicit statutory requirement. From a risk-control perspective, however, this lead time is reasonable — because the renewal review can also trigger deficiency requests, arranging the renewal on a shorter cycle would significantly raise the risk of supply interruption. The margin exists precisely to absorb work that cannot be predicted at the moment the renewal is launched.

• Fixed horizon — the registration certificate is valid for 5 years, and the whole compliance calendar should be built backwards from the expiry date.
• Renewal lead time — as a practical estimate, start the renewal at least 6 months before expiry to leave room for deficiency requests.
• Renewal substance — renewal is a fresh submission of updated product information, quality system conformity, and a safety and effectiveness update report, not a simple extension.

2. Legal basis

The table below sets out the regulatory elements surrounding certificate validity and renewal. Beyond the validity period and the recommended lead time, it records the content of the renewal dossier, the treatment of certificate transfers, the consistency duties that attach to import documents, and the submission channel, including the authentication requirement that now applies to portal access.

3. Expert insights

Insight 1: the five-year validity period is the time baseline for market access planning. Companies should schedule registration, importation, and localisation activities backwards from this five-year cycle rather than arranging them on an annual rolling basis. Working from the certificate horizon makes the renewal a planned project with owned milestones, while annual planning tends to push the renewal into the year of expiry, leaving too little room for the review cycle.

Insight 2: renewal is not a simple extension but a fresh submission of materials. The renewal dossier must include updated product information, evidence of the continued conformity of the quality system, and an updated safety and effectiveness report, so the workload approaches a part of the original registration effort. Companies that budget renewal effort as if it were a formality routinely underestimate it; the correct comparison is with a scaled-down first submission, not with a signature on a form.

Insight 3: the 6-month lead time is reasonable because it absorbs the deficiency cycle. The renewal review may likewise request supplementary materials, and a schedule arranged on a shorter cycle leaves the company exposed right around the expiry date. With a 6-month buffer, a deficiency request can be answered while the certificate remains valid; without it, the same request can arrive when there is no margin left, converting an administrative step into a supply continuity problem.

Insight 4: a certificate transfer must go through the variation procedure, not an automatic handover. This makes changing the licence holder an independent compliance action that must be planned ahead. The transfer is not bundled with the commercial transition automatically; it requires its own application, its own review, and its own lead time, so companies changing holders should treat it as a project in its own right rather than an appendix to the commercial negotiation.

Insight 5: consistency between the certificate and import documents must be maintained continuously. After any change to certificate information, such as a name or address change, the import documents must be updated in step. Invoices, packing lists, and batch numbers are checked against the certificate information, so allowing the two sets of data to drift apart creates clearance problems that surface at the border, precisely when the goods are already in transit.

4. Practical recommendations

• Plan the entire process backwards from the five-year validity baseline. Establish a long-term registration calendar so every renewal milestone has an owner and a date.
• Start renewal preparation according to the 6-month lead time. Do not schedule against the expiry date itself; the buffer is what absorbs deficiency requests.
• Treat the safety and effectiveness update report as a routine output. Producing it continuously avoids a scramble to compile it just before renewal.
• Follow the variation procedure when changing the licence holder. Reserve time for the release letter and notarisation within the changeover plan.
• Update import documents in step after any change to certificate information. Establish a linked-change mechanism so certificate edits automatically trigger document updates.

5. Verification checklist

• □ Confirmed that the registration certificate is valid for 5 years
• □ Established a five-year registration calendar
• □ Started renewal preparation according to the 6-month lead time
• □ Established a routine mechanism for producing the safety and effectiveness update report
• □ Planned the variation procedure for changing the licence holder
• □ Established a linked mechanism between certificate information changes and import documents
• □ Incorporated the registration ledger into management

Regulatory information verified as of 29 October 2026.

In the Southeast Asian market, GRZAN’s core strengths concentrate on three points. First, distinguishing the legislative progress of each ASEAN member state’s dedicated medical device law — Singapore, Malaysia, Thailand, Indonesia, the Philippines, Vietnam and others have each established their own written medical device regulatory framework, whereas Myanmar has not yet enacted a dedicated law; its rules are assembled from three layers: the technical framework of the ASEAN Medical Device Directive, administrative guidance from the competent authority, and the catch-all authorisation of the Public Health Law 1972, so compliance certainty is markedly lower than in markets where dedicated legislation is complete. Second, local authorised representative services, in which GRZAN can act as the statutory representative of the manufacturer in these countries, carrying registration submissions, regulatory communications, and post-market reporting obligations. Third, quality system and laboratory testing support, assisting in establishing a quality management system that meets ISO 13485 requirements and connecting with locally accredited laboratory resources.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Myanmar. Our team prepares the technical dossier to ASEAN CSDT structure, manages submission and deficiency responses with the Myanmar FDA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com